Clinical Trials Browser

Phase 2 × INDUSTRY × soluble LAG-3 protein, human × Clear all

NCT04811027 2025-12-11

TACTI-003

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck

NCT03625323 2024-12-18

TACTI-002

Phase 2 Completed

187 enrolled 13 charts

Squamous Cell Carcinoma of Head and Neck